Recruitment and differentiation of conventional dendritic cell precursors in tumors

Journal of Immunology

Volumn 184, Issue 3, 2010, Pages 1261-1267

  Diao, Jun ^a   Zhao, Jun ^a   Winter, Erin ^a   Cattral, Mark S ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LYMPHOID TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MELANOMA; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; SPLEEN; TUMOR; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL MOTION; CLASSIFICATION; COCULTURE; COLON TUMOR; EXPERIMENTAL MELANOMA; EXPERIMENTAL NEOPLASM; IMMUNOLOGY; PATHOLOGY; STEM CELL; STEM CELL TRANSPLANTATION; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; DENDRITIC CELLS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 77949327636     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903050     Document Type: Article

References (38)

1. Rabinovich, G. A., D. Gabrilovich, and E. M. Sotomayor. 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25: 267-296.
2. Pollard, J. W. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4: 71-78.
3. Gabrilovich, D. 2004. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4: 941-952.
4. Preynat-Seauve, O., P. Schuler, E. Contassot, F. Beermann, B. Huard, and L. E. French. 2006. Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection. J. Immunol. 176: 61-67.
5. Vicari, A. P., C. Chiodoni, C. Vaure, S. Aït-Yahia, C. Dercamp, F. Matsos, O. Reynard, C. Taverne, P. Merle, M. P. Colombo, et al. 2002. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J. Exp. Med. 196: 541-549.
6. Staveley-O'Carroll, K., E. Sotomayor, J. Montgomery, I. Borrello, L. Hwang, S. Fein, D. Pardoll, and H. Levitsky. 1998. Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc. Natl. Acad. Sci. USA 95: 1178-1183.
7. Zhou, G., C. G. Drake, and H. I. Levitsky. 2006. Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood 107: 628-636. (Pubitemid 43076387)
8. Horna, P., A. Cuenca, F. Cheng, J. Brayer, H. W. Wang, I. Borrello, H. Levitsky, and E. M. Sotomayor. 2006. In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity. Blood 107: 2871-2878.
9. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161.
10. Diao, J., E. Winter, W. Chen, C. Cantin, and M. S. Cattral. 2004. Characterization of distinct conventional and plasmacytoid dendritic cell-committed precursors in murine bone marrow. J. Immunol. 173: 1826-1833. (Pubitemid 38971616)
11. Diao, J., E. Winter, C. Cantin, W. Chen, L. Xu, D. Kelvin, J. Phillips, and M. S. Cattral. 2006. In situ replication of immediate dendritic cell (DC) precursors contributes to conventional DC homeostasis in lymphoid tissue. J. Immunol. 176: 7196-7206.
12. Naik, S. H., D. Metcalf, A. van Nieuwenhuijze, I. Wicks, L. Wu, M. O'Keeffe, and K. Shortman. 2006. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 7: 663-671.
13. Naik, S. H., P. Sathe, H. Y. Park, D. Metcalf, A. I. Proietto, A. Dakic, S. Carotta, M. O'Keeffe, M. Bahlo, A. Papenfuss, et al. 2007. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 8: 1217-1226.
14. + plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat. Immunol. 8: 1207-1216.
15. Diao, J., E. Winter, W. Chen, F. Xu, and M. S. Cattral. 2007. Antigen transmission by replicating antigen-bearing dendritic cells. J. Immunol. 179: 2713-2721.
16. Liu, K., G. D. Victora, T. A. Schwickert, P. Guermonprez, M. M. Meredith, K. Yao, F. F. Chu, G. J. Randolph, A. Y. Rudensky, and M. Nussenzweig. 2009. In vivo analysis of dendritic cell development and homeostasis. Science 324: 392-397.
17. Fogg, D. K., C. Sibon, C. Miled, S. Jung, P. Aucouturier, D. R. Littman, A. Cumano, and F. Geissmann. 2006. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311: 83-87. (Pubitemid 43063063)
18. Waskow, C., K. Liu, G. Darrasse-Jèze, P. Guermonprez, F. Ginhoux, M. Merad, T. Shengelia, K. Yao, and M. Nussenzweig. 2008. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9: 676-683.
19. Serbina, N. V., and E. G. Pamer. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7: 311-317.
20. 3CR1 in their response to inflammation. J. Exp. Med. 206: 595-606.
21. Diao, J., J. A. Smythe, C. Smyth, P. B. Rowe, and I. E. Alexander. 1999. Human PBMC-derived dendritic cells transduced with an adenovirus vector induce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro. Gene Ther. 6: 845-853. (Pubitemid 29243659)
22. Kamath, A. T., S. Henri, F. Battye, D. F. Tough, and K. Shortman. 2002. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100: 1734-1741.
23. - precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process. J. Immunol. 177: 2536-2542.
24. - pulmonary dendritic cell populations. J. Immunol. 180: 3019-3027.
25. Vicari, A. P., I. Treilleux, and S. Lebecque. 2004. Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines. Semin. Cancer Biol. 14: 161-169.
26. Yoneyama, H., K. Matsuno, Y. Zhang, T. Nishiwaki, M. Kitabatake, S. Ueha, S. Narumi, S. Morikawa, T. Ezaki, B. Lu, et al. 2004. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 16: 915-928.
27. Zhang, Y., H. Yoneyama, Y. Wang, S. Ishikawa, S. Hashimoto, J. L. Gao, P. Murphy, and K. Matsushima. 2004. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1α in mice. J. Natl. Cancer Inst. 96: 201-209.
28. Crittenden, M., M. Gough, K. Harrington, K. Olivier, J. Thompson, and R. G. Vile. 2003. Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity. Cancer Res. 63: 5505-5512. (Pubitemid 37139870)
29. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7: 19-30.
30. + T cell crosspriming in vivo. Immunity 24: 191-201.
31. Varol, C., L. Landsman, D. K. Fogg, L. Greenshtein, B. Gildor, R. Margalit, V. Kalchenko, F. Geissmann, and S. Jung. 2006. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med. 204: 171-180. (Pubitemid 46148767)
32. León, B., M. López-Bravo, and C. Ardavín. 2007. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26: 519-531. (Pubitemid 46602998)
33. Auffray, C., M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27: 669-692.
34. Jakubzick, C., M. Bogunovic, A. J. Bonito, E. L. Kuan, M. Merad, and G. J. Randolph. 2008. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J. Exp. Med. 205: 2839-2850.
35. Balkir, L., I. L. Tourkova, V. P. Makarenkova, G. V. Shurin, P. D. Robbins, X. M. Yin, G. Chatta, and M. R. Shurin. 2004. Comparative analysis of dendritic cells transduced with different anti-apoptotic molecules: sensitivity to tumor-induced apoptosis. J. Gene Med. 6: 537-544. (Pubitemid 40228069)
36. Conejo-Garcia, J. R., F. Benencia, M. C. Courreges, E. Kang, A. Mohamed-Hadley, R. J. Buckanovich, D. O. Holtz, A. Jenkins, H. Na, L. Zhang, et al. 2004. Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10: 950-958.
37. Liu, K., C. Waskow, X. Liu, K. Yao, J. Hoh, and M. Nussenzweig. 2007. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8: 578-583.
38. Palucka, A. K., H. Ueno, J. W. Fay, and J. Banchereau. 2007. Taming cancer by inducing immunity via dendritic cells. Immunol. Rev. 220: 129-150.